Popular Articles
Natural Remedies

POZEN Submits New Drug Application For VIMOVO™ (PN 400)
POZEN Inc. (NASDAQ:POZN), announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of VIMOVO™ (PN 400), the combination of enteric coated (EC) naproxen and immediate release esomeprazole. POZEN and AstraZeneca entered into a global co-development agreement for VIMOVO in August 2006. Pending regulatory approval, the proposed trade name is VIMOVO and the proposed indications are for the signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis in patients who are at risk for developing NSAID-associated ulcers.
generic viagra online
'Worrying Link' Between Ketamine Use And Severe Bladder Problems
Medical experts have warned of a "worrying link" between ketamine use and serious bladder and kidney problems.
News of the day
AlphaVax Announces Results From Initial Testing Of Its H1N1 (Swine) Influenza Vaccine
AlphaVax, Inc. announced today that it has completed process development and preclinical immunogenicity studies of its H1N1 (swine) influenza vaccine and will manufacture clinical trial material by the end of the month. This vaccine has shown good production yields as well as excellent immunogenicity, even after just a single inoculation.
Diagnostics

Enhanced Digital Breast Imaging From US Navy-Funded Technology

A breakthrough technology adapted for breast cancer detection based in part on research originally sponsored by the Office of Naval Research (ONR) is set to air July 23 during a CNN International news segment on Vital Signs, a program hosted by Dr. Sanjay Gupta. The technology, referred to by the U.S. Navy as enhanced digital imaging, developed out of the Navy"s need to improve capabilities to detect, localize and classify underwater mines. It later served as the point of departure for research conducted by the Naval Undersea Warfare Center, Division Newport (NUWC), part of the Naval Sea Systems Command (NAVSEA), designed to enhance the discrimination of data in complex underwater environments. Researchers at NUWC later patented the enhanced digital imaging process. The NUWC"s Technology Transfer program, also known as T2, made possible the transfer, commercialization and transition of the digital enhancement technology. The innovative concept was adapted by software developer, Advanced Image Enhancement (AIE), to provide improved enhancement of digital mammography images, thereby increasing the potential for improved reliability in the early detection of breast cancer. The Vital Signs July program series is reporting on select medical advances born from military research, both on the battlefield out of necessity and other s, highlighting how innovations eventually are applied in emergency rooms and medical procedures around the world. AIE technology complements existing radiology devices by yielding more detailed images, especially by uncovering the often faint cancerous lesions in dense and hard-to-detect breast tissue. It is expected to be commercially available in the late summer 2009. Peter Vietti Office of Naval Research


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):